Drugs / TIVc
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02256488 | Sep → Dec 2014 | — | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIVc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02256488 ↗ |
| Modality | Vaccine | “cell based trivalent subunit influenza vaccine (TIVc)” NCT02256488 ↗ |
| Route | Intramuscular | “Single IM (Intramuscular) administration dose of 0.5 mL of TIVc” NCT02256488 ↗ |